These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4204467)

  • 41. [Nalidixic acid in the treatment of complicated urinary tract infections in children].
    Gierup J; Ljunggren A
    Lakartidningen; 1966 Jun; 63(25):2435-40. PubMed ID: 5333466
    [No Abstract]   [Full Text] [Related]  

  • 42. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
    Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
    Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 44. [Urinal - for urinary track infections].
    Walmark
    Akush Ginekol (Sofiia); 2007; 46 Suppl 4():40-3. PubMed ID: 19705700
    [No Abstract]   [Full Text] [Related]  

  • 45. [Urinary tract infection and fluoroquinolone resistance].
    Luisoni A; Cometta A
    Rev Med Suisse Romande; 2003 Mar; 123(3):155-7. PubMed ID: 15095700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Possibility of influencing the antibacterial effect of erythromycin by changes of urinary pH in experimental E. coli infections of the urinary tract].
    Prát V; Loew H; Konícková L; Hatala M
    Cas Lek Cesk; 1971; 110(21):481-5. PubMed ID: 4931773
    [No Abstract]   [Full Text] [Related]  

  • 47. Prolonged treatment of urinary tract infections: changing concepts of therapy.
    Lampe WT
    J Urol; 1968 Oct; 100(4):556-9. PubMed ID: 4971110
    [No Abstract]   [Full Text] [Related]  

  • 48. An assessment of the value of prolonged use of methanamine mandelate in the treatment of chronic urinary tract infections.
    Budhraja SN; Rangiah T; Smile SR; Chidambaram M; Sharma KB
    Indian J Med Sci; 1972 Jun; 26(6):363-9. PubMed ID: 4644884
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy of chronic urinary tract infections with methenamine hippurate.
    Seneca H; Zinsser HH; Peer P
    J Urol; 1967 Jun; 97(6):1094-8. PubMed ID: 6028325
    [No Abstract]   [Full Text] [Related]  

  • 50. The prolonged use of methenamine hippurate in the treatment of chronic urinary tract infection.
    Gerstein AR; Okun R; Gonick HC; Wilner HI; Kleeman CR; Maxwell MH
    J Urol; 1968 Dec; 100(6):767-71. PubMed ID: 5696669
    [No Abstract]   [Full Text] [Related]  

  • 51. Methenamine hippurate ('Hiprex') in the treatment of chronic urinary tract infections: a trial in a geriatric hospital.
    Parvio S
    J Int Med Res; 1976; 4(2):111-4. PubMed ID: 1026539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-induced oxolinic acid crystalluria and nephrolithiasis.
    Daudon M; Reveilland RJ; Laurence C; Guenel J
    Clin Nephrol; 1987 Sep; 28(3):156. PubMed ID: 3311504
    [No Abstract]   [Full Text] [Related]  

  • 53. Methenamine hippurate in urinary tract infections in children: prophylaxis, treatment and side effects.
    Elo J; Sarna S; Ahava K; Lepo A
    J Antimicrob Chemother; 1978 Jul; 4(4):355-65. PubMed ID: 690036
    [No Abstract]   [Full Text] [Related]  

  • 54. The treatment of urinary infections with mandelamine (methenamine mandelate); a clinical study of 200 cases.
    CARROLL G; ALLEN HN
    J Urol; 1946 Jun; 55():674-81. PubMed ID: 20988077
    [No Abstract]   [Full Text] [Related]  

  • 55. Depression of urinary oestrogen values during methenamine mandelate administration.
    Mackay EV; Macafee CA; Anderson C
    Aust N Z J Obstet Gynaecol; 1967 May; 7(2):94-6. PubMed ID: 5233025
    [No Abstract]   [Full Text] [Related]  

  • 56. METHENAMINE MANDELATE (MANDELAMINE) IN URINARY TRACT INFECTIONS.
    ULLMAN A
    Med Times; 1964 Oct; 92():991-6. PubMed ID: 14200475
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevention of recurrent urinary tract infection with methenamine mandelate.
    Keswani RK; Chugh TD; Hooda RS; Beniwal JS
    Indian J Med Res; 1976 Aug; 64(8):1168-72. PubMed ID: 992846
    [No Abstract]   [Full Text] [Related]  

  • 58. Lipoid pneumonia caused by methenamine mandelate suspension.
    Timmerman RJ; Schroer JA
    JAMA; 1973 Sep; 225(12):1524-5. PubMed ID: 4740722
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of urinary tract infections in women with buccosperin].
    BRAZEL E
    Ther Ggw; 1956 Mar; 95(3):104-5. PubMed ID: 13324816
    [No Abstract]   [Full Text] [Related]  

  • 60. [Laboratory and clinical studies on hippramine].
    Kawada Y; Nishimura Y; Nishiura T
    Nihon Hinyokika Gakkai Zasshi; 1969 Jan; 60(1):71-9. PubMed ID: 5813607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.